0001104659-22-009303.txt : 20220131 0001104659-22-009303.hdr.sgml : 20220131 20220131092945 ACCESSION NUMBER: 0001104659-22-009303 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220131 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220131 DATE AS OF CHANGE: 20220131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XpresSpa Group, Inc. CENTRAL INDEX KEY: 0001410428 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PERSONAL SERVICES [7200] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34785 FILM NUMBER: 22571623 BUSINESS ADDRESS: STREET 1: 254 WEST 31ST STREET STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: (212) 309-7549 MAIL ADDRESS: STREET 1: 254 WEST 31ST STREET STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: Form Holdings, Inc. DATE OF NAME CHANGE: 20180102 FORMER COMPANY: FORMER CONFORMED NAME: XpresSpa Group, Inc. DATE OF NAME CHANGE: 20180102 FORMER COMPANY: FORMER CONFORMED NAME: FORM Holdings Corp. DATE OF NAME CHANGE: 20160509 8-K 1 tm224908d1_8k.htm FORM 8-K
0001410428 false 0001410428 2022-01-31 2022-01-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(D) of the Securities Exchange Act Of 1934

 

Date of report (Date of earliest event reported): January 31, 2022

 

XpresSpa Group, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

001-34785   20-4988129
(Commission File Number)   (IRS Employer Identification No.)

 

254 West 31st Street, 11th Floor, New York, New York   10001
(Address of Principal Executive Offices)   (Zip Code)

 

(212) 309-7549

(Registrant’s Telephone Number, Including Area Code)

  

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.01 per share   XSPA   The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨ 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ 

 

 

 

 

 

  

Item 7.01.Regulation FD Disclosure.

 

On January 31, 2022, XpresSpa Group, Inc. (the “Company”) issued a press release announcing the extension of their initial $2 million airport-based biosurveillance program with the Centers for Disease Control and Prevention (CDC) through its subsidiary XpresCheck®, bringing the total contract to $5.6 million.

 

The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and the contents of the press release are hereby incorporated herein by reference.

 

The information set forth in or incorporated by reference into this Item 7.01, including the information set forth in Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. In addition, this report (including Exhibit 99.1) shall not be deemed an admission as to the materiality of any information contained herein that is required to be disclosed solely as a requirement of Item 7.01.

 

 

Item 9.01.Financial Statements and Exhibits.

 

(d)Exhibits.

 

Exhibit
Number		 Description
   
99.1 Press Release, dated January 31, 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  XPRESSPA GROUP, INC.
     
Date: January 31, 2022 By: /s/ Cara Soffer
  Name:  Cara Soffer
  Title: General Counsel

 

 

 

 EX-99.1 2 tm224908d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

XpresSpa Group Extends Collaboration with Centers for Disease Control and

Prevention (CDC) to Conduct Ongoing COVID-19 Biosurveillance at U.S. Airports

 

SARS-CoV-2 Variant Identification Program Expands Beyond Initial Pilot; Now Totals $5.6 Million

 

NEW YORK, Jan. 31, 2022 -- XpresSpa Group, Inc. (Nasdaq: XSPA), a travel health and wellness company, today announced the extension of their initial $2 million airport-based biosurveillance program with the Centers for Disease Control and Prevention (CDC) through its subsidiary XpresCheck®, bringing the total contract to $5.6 million.

 

First launched in September 2021, the COVID-19 biosurveillance program consisted of an 8-week pilot that focuses on the importation of emerging SARS-CoV-2 variants in the United States on flights originating from India.

 

“During the Thanksgiving holiday, we worked closely with the CDC to pivot and expand our surveillance program to screen for the new, highly contagious Omicron variant that was identified just days earlier in Africa,” said Ezra Ernst, XpresCheck’s recently appointed chief executive officer. “Together, with our testing partner, Concentric by Ginkgo, we successfully expanded the program to monitor additional flights from around the globe.”

 

With the recent expansion, the program now tests passengers entering the United States from seven African countries, including passengers making connections through the United Kingdom, France, Germany and Brazil – countries that have been identified as Level 4 Risk Assessment for COVID-19. Initially, the biosurveillance program provided testing for travelers arriving from India at three key United States airports including John F. Kennedy International Airport, Newark-Liberty International Airport and San Francisco International Airport. The expansion also included the addition of Hartsfield-Jackson Atlanta International Airport, bringing the number of testing sites to four.

 

“For the past 3 months, XpresCheck and their testing partner, Concentric by Gingko, demonstrated that a traveler-based SARS-CoV-2 viral genomic surveillance program can help detect emerging SARS-CoV-2 variants in the United States,” said Dr. Cindy R. Friedman, chief of CDC’s Travelers’ Health Branch. “In fact, following the rapid expansion over the Thanksgiving break, the program detected the first documented U.S. cases of Omicron sub-lineage BA.2 and BA.3,” added Friedman.

 

Operationally, the current expansion utilizes the same tests and processes as the pilot program. Passengers take a PCR test, which is combined with 5-10 other samples and sent to the lab to determine the presence of COVID-19. If the presence of COVID-19 is detected in the pooled sample, the viral samples will undergo genomic sequencing to identify the presence of any variants, such as the Omicron variant. In addition to the pooled tests, participating travelers are provided a free take-home PCR test which they are recommended to take within 3-5 days after their arrival. Both tests help the CDC understand which variants are making their way to the U.S.

 

 

 

 

“It’s a source of pride for me and all the XpresCheck employees that we are making a real impact in the response to COVID-19,” said Scott Milford, the recently-appointed Chief Executive Officer of XpresSpa Group. “We are creating a travel-based surveillance platform that can be used to address future emerging threats and help protect our borders. With the expansion, we are one step closer to enabling program near real-time detection of novel COVID-19 variants at our borders.”

 

###

 

Funding for this project is made possible (in part) by the Centers for Disease Control and Prevention. The views expressed in written materials or publications do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 

About XpresSpa Group, Inc.

 

XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading global health and wellness holding company operating three distinct brands: XpresCheck®, XpresSpa®, Treat™. XpresCheck is a leading on-site airport provider of COVID-19 screening and testing with 14 locations in 12 domestic airports. XpresSpa is a leading airport retailer of spa services and related health and wellness products, with 45 locations in 21 airports globally. Treat is a travel health and wellness brand that is providing on-demand access to healthcare through technology and personalized services. The Company also recently acquired HyperPointe™, a leading digital healthcare and data analytics relationship marketing agency servicing the global healthcare and pharmaceutical industry

 

To learn more about XpresSpa Group, visit: www.XpresSpaGroup.com.

To learn more about XpresCheck, visit: www.XpresCheck.com.

To learn more about XpresSpa, visit www.XpresSpa.com.

To learn more about Treat, visit: www.Treat.com.

To learn more about HyperPointe, visit www.Hyperpointe.com

 

Twitter: @xprescheck and Instagram: @realxprescheck

Twitter: @XpresSpa and Instagram: @XpresSpa

Twitter: @Treat_Care and Instagram: @treat_care

 

 

 

 

Forward-Looking Statements

 

This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. In particular, these statements include, without limitation, statements about our expectations relating to our new XpresCheck™ concept, being able to expand testing to other communicable diseases as well as administer vaccinations for the seasonal flu, our positioning to be part of the national rollout of various COVID-19 vaccinations, the degree to which our public testing model assists passengers meet testing requirements in select states and countries, our ability to identify and gain access to the latest and best COVID-19 testing methodologies and equipment, and our overall ability to manage the regulatory challenges associated with this business line. Forward-looking statements relating to expectations about future results or events are based upon information available to XpresSpa Group as of today's date and are not guarantees of the future performance of the company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in XpresSpa Group’s most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q, recent Current Reports on Form 8-K and other Securities and Exchange Commission filings. All subsequent written and oral forward-looking statements concerning XpresSpa Group, or other matters and attributable to XpresSpa Group or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XpresSpa Group does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.

 

Investor Relations:

ICR

Raphael Gross

ir@xpresspagroup.com

(203) 682-8253

 

Media:

Julie Ferguson

Julie@jfprmedia.com

(312) 385-0098

 

About Ginkgo Bioworks

 

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo is also actively supporting a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit www.ginkgobioworks.com.

 

Media:

press@ginkgobioworks.com

 

Investor Relations:

investors@ginkgobioworks.com

 

 

 

 EX-101.SCH 3 xspa-20220131.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 xspa-20220131_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 xspa-20220131_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Cover
Jan. 31, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 31, 2022
Entity File Number 001-34785
Entity Registrant Name XpresSpa Group, Inc.
Entity Central Index Key 0001410428
Entity Tax Identification Number 20-4988129
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 254 West 31st Street
Entity Address, Address Line Two 11th Floor
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10001
City Area Code 212
Local Phone Number 309-7549
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol XSPA
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 7 tm224908d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001410428 2022-01-31 2022-01-31 iso4217:USD shares iso4217:USD shares 0001410428 false 8-K 2022-01-31 XpresSpa Group, Inc. DE 001-34785 20-4988129 254 West 31st Street 11th Floor New York NY 10001 212 309-7549 false false false false Common Stock, par value $0.01 per share XSPA NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 1 122 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://vringo.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm224908d1_8k.htm tm224908d1_ex99-1.htm xspa-20220131.xsd xspa-20220131_lab.xml xspa-20220131_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm224908d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "tm224908d1_8k.htm" ] }, "labelLink": { "local": [ "xspa-20220131_lab.xml" ] }, "presentationLink": { "local": [ "xspa-20220131_pre.xml" ] }, "schema": { "local": [ "xspa-20220131.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 122, "memberCustom": 0, "memberStandard": 0, "nsprefix": "xspa", "nsuri": "http://vringo.com/20220131", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm224908d1_8k.htm", "contextRef": "From2022-01-31to2022-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://vringo.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm224908d1_8k.htm", "contextRef": "From2022-01-31to2022-01-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 14 0001104659-22-009303-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-22-009303-xbrl.zip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